Renalytix Plc Share Price (RENX)

Topped up 6k worth , gut feeling suggests we could easily start on an upward trajectory!!… time will tell

Life in the old dog yet.......

Goodness me, an upward tick on AIM

11:23:08 1.76 42,328 744.97 O

10:33:06 1.89 42,328 800.00 O

Hi all, long-term investor, first-time poster.

I’ve sat on the sidelines quietly for years. The current forum discussion seems to revolve around cash burn, runway, and dilution—but if we’re being honest, those are symptoms. The root cause is that commercial adoption hasn’t reached escape velocity.

We have a fantastic technology, but potential doesn’t equal scaled adoption. At present, the company remains effectively stagnant.

I’m starting to wonder if Renalytix should pivot its core identity: Stop positioning as a 'diagnostics company' and start operating as a 'healthcare cost-reduction company.'

If the test reliably identifies high-risk patients early enough to influence clinical outcomes, the value isn't the test kit—it's the massive reduction in long-term dialysis expenditure. While the new lab facility is a great move for operational efficiency, it’s just fixing the middle. The real elephant in the room is downstream: the effectiveness of the sales engine.

Big pharma and diagnostics giants have the embedded networks needed to market this at scale. I suspect the 'sharks' spotted this opportunity years ago, and they’re content to sit on their hands and wait to see if this becomes available at bargain-basement prices—and frankly, looking at the current valuation, we're already there.

How do others here view the Carna Health partnership? Is it the start of a genuine pivot to an outcomes-based model, or just another pilot program that won't move the revenue needle?